Sector portfolio · Private equity · United States

Vivo Capital's Pharma portfolio

Vivo Capital has backed 17 Pharma startups in rounds we track, $2.3B between them, shown by the stage each has reached. The best-funded is Zenas Biopharma.

17startups backed
4stages
$2.3Braised between them
Stage not reportedbiggest stage

Vivo Capital's whole portfolioVivo Capital's profile

Stage not reported

8

Series C and later

4

Series B

3

Series A

2

Segment by segment

Stage not reported

8 startups · $669M raised

  1. Harmony BiosciencesHarmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.United States$248M
  2. Tarsus PharmaceuticalsTarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.United States$125M
  3. Mereo BiopharmaMereo is a new UK-based speciality biopharmaceutical company.United Kingdom$92M
  4. Whitehawk TherapeuticsWhitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.United States$88M
  5. Elevation OncologyElevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.United States$50M
  6. CAMP4 TherapeuticsCAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.United States$30M
  7. Ventyx BiosciencesVentyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.United States$27M
  8. ALX OncologyALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.United States$10M

Series C and later

4 startups · $938M raised

  1. Zenas BioPharmaZenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.United States$420M
  2. ORIC PharmaceuticalsORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.United States$248M
  3. Poseida TherapeuticsPoseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.United States$217M
  4. 35Pharma35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.Canada$53M

Series B

3 startups · $375M raised

  1. AllakosAllakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.United States$294M
  2. AttralusAttralus is a clinical-stage biopharmaceutical company focused on developing innovative medicines and diagnostics for systemic amyloidosis.United States$56M
  3. Immune-Onc TherapeuticsImmune-Onc Therapeutics is a clinical-stage biopharmaceutical company based in Palo Alto, California.United States$25M

Series A

2 startups · $337M raised

  1. Compass TherapeuticsCompass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.United States$257M
  2. Citrine MedicineCitrine Medicine is a rare disease-focused pharmaceutical firm.-$80M

How this map is made. Every startup here works in Pharma and has raised money in a round we track that names Vivo Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioVivo Capital's Biotech portfolio67 startups · $11BPortfolio mapVivo Capital portfolio map98 startups · $17BCo-investorsWho invests with Vivo Capital73 co-investorsSector portfolioRA Capital Management's Biotech portfolio197 startups · $38BSector portfolioOrbiMed's Biotech portfolio176 startups · $28BSector portfolioPioneer Fund's AI portfolio171 startups · $2.8B

Raising from investors like Vivo Capital?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps